Mursla Bio enters the US market with strategic expansion
Mursla Bio launches US strategy to bring its novel liquid biopsy tests – based on extracellular vesicle technology – to patients
Mursla Bio presents breakthrough liquid biopsy technology for extracellular vesicles in Cell Press
Novel and scalable analysis of extracellular vesicles sub-types detailed in Cell Press’ iScience
Mursla Bio helps shape the standardisation of EV-based liquid biopsy for clinical use
Mursla Bio participates in a unique global initiative to standardise the clinical use of novel EV-based biomarkers for liquid biopsy
Mursla Bio to present at Bio-International 2023
Mursla Bio was selected to present at the largest pharmaceutical and biotech partnering event
Mursla Bio invited to Health Tech Showcase at London Stock Exchange
Showcase spotlights Mursla Bio's first-in-class science and upcoming milestones for flagship product launch